CRP and systemic lupus erythematosus: In conclusion, although a few studies indicate a higher prevalence of MEFV mutations among SLE patients, FMF may confer a protective effect against SLE via mechanisms involving CRP and SAP, which could account for the milder SLE symptoms observed in patients with both conditions.